NeuroPace Inc
NPCE- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001528287
No open-market purchases or sales by NeuroPace Inc insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $422.4M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in NeuroPace Inc as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 113
- +15 vs. Q4 2025
- Shares held
- 26.5M
- +2.27M (+9.4%) vs. Q4 2025
- Total value
- $347.9M
- −$25.4M (−6.8%) vs. Q4 2025
- New holders
- 28
- 39 more added
- Sold out
- 13
- 36 more reduced
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NPCE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 112 | $422.4M |
| Q1 2026 | 113 | $347.9M |
| Q4 2025 | 100 | $405.9M |
| Q3 2025 | 80 | $267.5M |
| Q2 2025 | 99 | $250.7M |
| Q1 2025 | 90 | $294.1M |
| Q4 2024 | 62 | $233.5M |
| Q3 2024 | 48 | $103.1M |
| Q2 2024 | 51 | $109.1M |
| Q1 2024 | 54 | $176.4M |
| Q4 2023 | 41 | $130.8M |
| Q3 2023 | 25 | $175.9M |
| Q2 2023 | 22 | $78.6M |
| Q1 2023 | 24 | $82.0M |
| Q4 2022 | 24 | $25.9M |
| Q3 2022 | 28 | $68.1M |
| Q2 2022 | 32 | $91.2M |
| Q1 2022 | 40 | $149.5M |
| Q4 2021 | 41 | $181.5M |
| Q3 2021 | 39 | $177.4M |
| Q2 2021 | 44 | $259.5M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding NeuroPace Inc; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State Street Corp | 497,546 | $6.54M | 0.00% | +49,682+11.1% | Added |
| FMR LLC | 553,529 | $7.28M | 0.00% | −71,418−11.4% | Reduced |
| Geode Capital Management, LLC | 618,119 | $8.13M | 0.00% | +21,871+3.7% | Added |
| Armistice Capital, LLC | 692,000 | $9.10M | 0.30% | −100,000−12.6% | Reduced |
| Deutsche Bank AG | 932,090 | $12.3M | 0.00% | +2,568+0.3% | Added |
| Vanguard Capital Management LLC | 1,123,711 | $14.8M | 0.00% | +1,123,711 | New |
| Driehaus Capital Management LLC | 1,451,611 | $19.1M | 0.14% | −59,678−3.9% | Reduced |
| OrbiMed Advisors LLC | 2,096,527 | $27.6M | 0.63% | −309,808−12.9% | Reduced |
| BlackRock, Inc. | 2,346,333 | $30.9M | 0.00% | −37,584−1.6% | Reduced |
| First Light Asset Management, LLC | 2,459,966 | $32.3M | 2.90% | +1,110,484+82.3% | Added |
| Morgan Stanley | 2,566,839 | $33.8M | 0.00% | +19,055+0.7% | Added |
| Soleus Capital Management, L.P. | 2,932,207 | $38.6M | 1.56% | +228,999+8.5% | Added |
| Polar Capital Holdings Plc | 3,298,104 | $43.4M | 0.19% | +419,581+14.6% | Added |
| Nantahala Capital Management, LLC | 0 | $0 | 0.00% | −295,089−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −228,847−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −58,418−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −51,100−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −31,803−100.0% | Sold out |
| PharVision Advisers, LLC | 0 | $0 | 0.00% | −11,699−100.0% | Sold out |
| PFM Health Sciences, LP | 0 | $0 | 0.00% | −11,329−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −10,185−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −8,952−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −3,245−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −790−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Kotler Kevin | – | – | – | – | Not filed |